Meng Fan-Chieh, Lee Chiu-Yang
Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei.
Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei.
Quant Imaging Med Surg. 2023 Jan 1;13(1):282-292. doi: 10.21037/qims-21-1164. Epub 2022 Nov 7.
In order to achieve better hemostasis of puncture holes in the femoral artery (FA) after an endovascular procedure, this study evaluated the effect and safety of manual compression (MC) with QuikClot Combat Gauze (QIC) and with mechanical compression (using a C-clamp) of the common access site, the FA, in patients with peripheral arterial occlusive disease (PAOD) combined with anterior femoral artery calcification (AFAC).
We prospectively reviewed 100 patients receiving either MC with QIC or mechanical compression (control group) after endovascular intervention for PAOD plus AFAC from February 2014 to September 2018 in a single unit, which was assessed using computerized tomography angiography (CTA).
The mean time to completion of hemostasis was 30±0 minutes in the control group and 18±2.20 minutes in the QIC group (P<0.001). The time to ambulation of the QIC and control groups was 4.38±0.46 and 4.86±0.30 hours (P<0.001), respectively. Eight (16%) patients in the control group had hematoma, as compared with one patient (2%) in the QIC group (P=0.031), while sixteen (32%) patients in the control group had ecchymosis, as compared with four (8%) in the QIC group (P=0.005). Use of QIC and coronary artery disease (CAD) were identified as independent factors correlated with an increased risk of minor complications.
QIC facilitated effective and safe hemostasis in patients with PAOD and AFAC.
为了在血管内介入术后更好地实现股动脉(FA)穿刺孔止血,本研究评估了使用快速凝血战斗纱布(QIC)进行手动压迫(MC)以及对合并股前动脉钙化(AFAC)的外周动脉闭塞性疾病(PAOD)患者的共同穿刺部位即股动脉使用机械压迫(使用C形夹)的效果和安全性。
我们前瞻性地回顾了2014年2月至2018年9月在单一单位接受PAOD加AFAC血管内介入术后使用QIC进行MC或机械压迫(对照组)的100例患者,使用计算机断层血管造影(CTA)进行评估。
对照组止血完成的平均时间为30±0分钟,QIC组为18±2.20分钟(P<0.001)。QIC组和对照组的下床活动时间分别为4.38±0.46小时和4.86±0.30小时(P<0.001)。对照组有8例(16%)患者出现血肿,而QIC组有1例(2%)患者出现血肿(P=0.031),对照组有16例(32%)患者出现瘀斑,而QIC组有4例(8%)患者出现瘀斑(P=0.005)。使用QIC和冠状动脉疾病(CAD)被确定为与轻微并发症风险增加相关的独立因素。
QIC有助于PAOD和AFAC患者实现有效且安全的止血。